SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES

Scope & Guideline

Advancing Knowledge in Lung Health

Introduction

Welcome to your portal for understanding SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1124-0490
PublisherMATTIOLI 1885
Support Open AccessNo
CountryItaly
TypeJournal
Convergefrom 1996 to 2024
AbbreviationSARCOIDOSIS VASC DIF / Sarcoidosis Vasc. Diffus. Lung Dis.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressVIA DELLA LODESANA 649-SX, FIDENZA 43046 PR, ITALY

Aims and Scopes

The journal 'Sarcoidosis, Vasculitis and Diffuse Lung Diseases' is dedicated to advancing the understanding and treatment of sarcoidosis and related conditions, with an emphasis on clinical research, diagnostics, and therapeutic strategies.
  1. Clinical Research on Sarcoidosis:
    The journal focuses on clinical studies that investigate the epidemiology, pathophysiology, and treatment outcomes of sarcoidosis, providing insights into patient management and care.
  2. Vasculitis and Interstitial Lung Diseases:
    It includes research on various forms of vasculitis and interstitial lung diseases, highlighting their clinical implications and management.
  3. Diagnostic Techniques and Biomarkers:
    The journal emphasizes the development and validation of diagnostic techniques and biomarkers for sarcoidosis and related conditions, improving diagnostic accuracy and patient monitoring.
  4. Prognostic Factors and Treatment Efficacy:
    Research on prognostic factors that influence treatment outcomes and the efficacy of various therapeutic agents in sarcoidosis and lung diseases is a core focus.
  5. Multidisciplinary Approaches:
    The journal encourages studies that adopt multidisciplinary approaches to understand the complex interactions of sarcoidosis with other diseases, enhancing holistic patient care.
Recent publications in 'Sarcoidosis, Vasculitis and Diffuse Lung Diseases' reflect evolving trends and emerging themes that are gaining traction in the field.
  1. Impact of COVID-19 on Sarcoidosis Patients:
    There is a growing focus on understanding the effects of COVID-19 on patients with sarcoidosis, particularly the implications for disease management and outcomes following infection.
  2. Integration of Telehealth and Remote Monitoring:
    The emergence of telehealth solutions and remote monitoring technologies for managing sarcoidosis and interstitial lung diseases has become a significant area of interest.
  3. Multimorbidity and Comorbid Conditions:
    Research exploring the interplay between sarcoidosis and other comorbid conditions, such as cardiovascular diseases and mental health issues, is increasingly prominent, highlighting the need for comprehensive care.
  4. Use of Advanced Imaging Techniques:
    There is an upward trend in studies utilizing advanced imaging techniques, such as high-resolution computed tomography, to assess disease progression and treatment response in sarcoidosis.
  5. Personalized Medicine Approaches:
    An emerging theme is the exploration of personalized medicine in sarcoidosis treatment, focusing on tailoring therapies based on individual patient characteristics and disease profiles.

Declining or Waning

While the journal has maintained a robust focus on sarcoidosis and related lung diseases, certain areas appear to be declining in prominence within recent publications.
  1. Case Reports of Rare Manifestations:
    There has been a noticeable decline in the publication of case reports detailing rare manifestations of sarcoidosis, suggesting a shift towards more generalizable research findings.
  2. Basic Science Studies:
    Research focused on the basic science aspects of sarcoidosis, such as cellular and molecular mechanisms, has seen decreased representation, indicating a preference for clinical and translational studies.
  3. Longitudinal Studies on Historical Data:
    Longitudinal studies utilizing historical data for sarcoidosis outcomes are less frequently published, possibly reflecting a trend towards more contemporary, real-time data analysis.

Similar Journals

JOURNAL OF CLINICAL INVESTIGATION

Shaping the future of medicine, one study at a time.
Publisher: AMER SOC CLINICAL INVESTIGATION INCISSN: 0021-9738Frequency: 12 issues/year

JOURNAL OF CLINICAL INVESTIGATION is a premier scholarly journal published by the American Society for Clinical Investigation, dedicated to advancing the field of clinical research and medicine since its inception in 1945. With an impressive impact factor and ranked Q1 in the field of Medicine (miscellaneous), it stands out as a leading source of high-quality research, reflecting its exceptional position in Scopus ranking as #13 out of 636 in General Medicine, placing it in the 98th percentile. The journal focuses on groundbreaking studies that explore the underlying mechanisms of human disease, facilitating a deeper understanding that drives clinical practice and innovation. Although it is not an open-access journal, the insights and findings published in this esteemed journal are essential reading for researchers, healthcare professionals, and students aspiring to contribute to the dynamic landscape of clinical investigation. Published in the United States, it continues to shape the dialogue and advancement within the medical community through its rigorous peer-review process and commitment to excellence.

ANNALS OF CLINICAL AND LABORATORY SCIENCE

Empowering Research for Better Health Outcomes
Publisher: ASSOC CLINICAL SCIENTISTSISSN: 0091-7370Frequency: 6 issues/year

ANNALS OF CLINICAL AND LABORATORY SCIENCE, published by the Association of Clinical Scientists, is a pivotal journal in the fields of clinical biochemistry, hematology, immunology, and medical laboratory technology. Since its inception in 1971, this journal has become a vital resource for researchers and practitioners aiming to advance their knowledge and skills in laboratory sciences. Although currently not an open access journal, its rich repository of peer-reviewed articles and studies contributes significantly to the academic discourse in diagnostic and therapeutic practices. The journal is categorized in various quartiles, reflecting its impact and contributions to multiple scientific domains, such as Q4 in Clinical Biochemistry and Q3 in Pathology and Forensic Medicine as of 2023. With an extensive convergence of years up to 2024, it proves to be a timeless source for emerging trends and research innovations. The ANNALS OF CLINICAL AND LABORATORY SCIENCE not only supports the professional development of its readers but also encourages interdisciplinary collaboration, making it an essential tool for professionals, students, and researchers dedicated to improving health outcomes through advanced laboratory sciences.

Kidney Diseases

Elevating the standard of care in kidney disease management.
Publisher: KARGERISSN: 2296-9381Frequency: 6 issues/year

Kidney Diseases is an esteemed open-access journal published by KARGER that has been at the forefront of nephrology research since its inception in 2015. With an impressive Scopus ranking of #13 out of 81 in the field of Medicine Nephrology, placing it in the top 84th percentile, the journal has established itself as a vital resource for researchers, clinicians, and students interested in advancing knowledge on kidney health, disorders, and innovative treatment strategies. This journal aims to disseminate cutting-edge findings and clinical insights over a converged publication span from 2019 to 2024, fostering global collaboration and dialogue within the scientific community. With its commitment to open access, Kidney Diseases ensures that critical research is freely accessible, promoting wider dissemination of knowledge and the development of effective therapeutic interventions.

CHEST

Elevating the standards of pulmonary medicine research.
Publisher: ELSEVIERISSN: 0012-3692Frequency: 12 issues/year

CHEST is a premier journal published by Elsevier, focusing on the vital fields of cardiology, critical care, and pulmonary medicine. Established in 1970, this esteemed journal has continually provided authoritative research, reviews, and clinical studies, catering to a global audience of healthcare professionals, researchers, and students. With an impressive impact factor, CHEST ranks in the top quartile (Q1) across its core categories according to the latest Scopus metrics, securing its position as a leading resource within cardiology (Rank #16), pulmonary (Rank #9), and critical care (Rank #8). Published quarterly, it offers a wealth of knowledge essential for advancing understanding and improving patient outcomes in these critical areas of healthcare. Researchers and practitioners are encouraged to submit their work, contributing to the ongoing discourse that shapes innovative practices and policies in respiratory and cardiovascular health.

JOURNAL OF NEPHROLOGY

Transforming kidney health through academic excellence.
Publisher: SPRINGER HEIDELBERGISSN: 1121-8428Frequency: 9 issues/year

JOURNAL OF NEPHROLOGY is a premier academic journal dedicated to the field of nephrology, published by Springer Heidelberg. With its ISSN 1121-8428 and E-ISSN 1724-6059, this journal serves as a dynamic platform for disseminating high-quality research and groundbreaking findings in kidney health and disease. Since its inception in 1989, it has established itself as a vital resource for professionals, researchers, and students, consistently ranking in the top quartile (Q1) of nephrology journals and securing an impressive Scopus rank of #19 out of 81, placing it in the 77th percentile. Although it operates under a subscription model, the journal fosters an inclusive academic environment where critical discussions and innovative approaches to nephrological challenges are encouraged. With a commitment to advancing knowledge and practice in nephrology, JOURNAL OF NEPHROLOGY remains an essential resource for anyone who seeks to stay at the forefront of kidney research and clinical care.

Indian Journal of Respiratory Care

Connecting Experts to Transform Respiratory Care
Publisher: JAYPEE BROTHERS MEDICAL PUBLISHERS PVT LTDISSN: 2277-9019Frequency: 4 issues/year

Welcome to the Indian Journal of Respiratory Care, a premier platform dedicated to advancing research and clinical practices in the field of respiratory health. Published by JAYPEE BROTHERS MEDICAL PUBLISHERS PVT LTD, this journal has established itself as a crucial resource for researchers, healthcare professionals, and educators since embracing an Open Access model in 2012, ensuring maximum visibility and accessibility of vital research findings. The journal aims to disseminate high-quality articles encompassing a wide range of topics, including but not limited to, respiratory diseases, pulmonary care, and innovative treatment approaches. With its commitment to fostering collaboration and knowledge exchange, the Indian Journal of Respiratory Care is poised to make a significant impact in the ever-evolving landscape of respiratory medicine. As the field continues to grow, this journal serves as an essential touchpoint for those invested in enhancing patient care and outcomes.

RESPIRATORY MEDICINE

Exploring Breakthroughs in Lung Health
Publisher: W B SAUNDERS CO LTDISSN: 0954-6111Frequency: 12 issues/year

Respiratory Medicine is a leading journal in the field of pulmonary and respiratory medicine, dedicated to advancing knowledge and research from 1989 to 2024. Published by W B Saunders Co Ltd, this esteemed journal is recognized for its high impact, reflected in its Q1 quartile ranking in 2023 within the category of Pulmonary and Respiratory Medicine and its impressive Scopus ranking of 27 out of 155 journals, placing it in the 82nd percentile. With a focus on publishing groundbreaking research, comprehensive reviews, and innovative practices, Respiratory Medicine serves as an essential resource for health professionals, researchers, and students aiming to improve patient outcomes and understand complex respiratory conditions. While the journal is not Open Access, its contributions to the scientific community are invaluable, providing insights that drive both academic and clinical advancements in respiratory health.

INFECTION

Elevating Knowledge in Infectious Diseases
Publisher: SPRINGER HEIDELBERGISSN: 0300-8126Frequency: 6 issues/year

INFECTION is a prestigious journal, published by Springer Heidelberg, that serves as a leading platform for the dissemination of critical research in the fields of Infectious Diseases, Microbiology, and Medicine. With an impressive Q1 ranking in multiple categories such as Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology, the journal is recognized for its high-quality content and impactful contributions to the scientific community, as evidenced by its Scopus rankings placing it in the top 10th percentiles. Since its inception in 1973, and projected to continue until 2024, INFECTION has established itself as a vital resource for researchers, healthcare professionals, and students keen to explore the latest findings and advancements in infectious diseases. The journal provides a rigorous peer-review process, ensuring that only high-quality studies are published, making it an essential read for those seeking to deepen their understanding and stay abreast of the rapidly evolving landscape in infection research.

Canadian Respiratory Journal

Connecting researchers and practitioners for better respiratory care.
Publisher: HINDAWI LTDISSN: 1198-2241Frequency: 1 issue/year

The Canadian Respiratory Journal is a prominent peer-reviewed publication dedicated to advancing knowledge in the field of pulmonary and respiratory medicine. Published by HINDAWI LTD and based in Egypt, this journal has been an Open Access platform since 1994, ensuring broad dissemination of vital research findings to a global audience. With an ISSN of 1198-2241 and an E-ISSN of 1916-7245, the journal plays a significant role in shaping respiratory health discussions, evidenced by its 2023 category rankings of Q2 in Medicine (miscellaneous) and Q3 in Pulmonary and Respiratory Medicine. The journal consistently publishes high-quality research, reviews, and clinical guidelines that resonate with practitioners, researchers, and students alike. It serves as an essential resource for those seeking to stay at the forefront of developments in respiratory health, reflecting its commitment to enhancing practice and informing policy while recognizing its place in this vital medical field.

Respiratory Investigation

Elevating research for better respiratory care.
Publisher: ELSEVIERISSN: 2212-5345Frequency: 6 issues/year

Respiratory Investigation is a leading peer-reviewed journal published by Elsevier, dedicated to advancing the field of Pulmonary and Respiratory Medicine. Since its inception in 2012, the journal has grown to become a vital resource for researchers, clinicians, and students alike, providing a platform for high-quality research articles, reviews, and clinical studies. With a commendable impact factor and ranked in the Q2 category of Scopus' 2023 metrics, it stands at rank #57 out of 155 in its field, illustrating its importance and influence within the academic community. Although the journal operates on a subscription basis, it remains committed to disseminating essential findings that enhance the understanding and treatment of respiratory diseases. Set against the innovative backdrop of the Netherlands, Respiratory Investigation not only serves as a conduit for scholarly exchange but also plays a critical role in shaping future research directions and clinical practices.